{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:18:25Z","timestamp":1778923105885,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015496","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","doi-asserted-by":"publisher","award":["CB07\/502"],"award-info":[{"award-number":["CB07\/502"]}],"id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","doi-asserted-by":"publisher","award":["PI2024\/01"],"award-info":[{"award-number":["PI2024\/01"]}],"id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["EP\/X025608\/1"],"award-info":[{"award-number":["EP\/X025608\/1"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["GA-101071485"],"award-info":[{"award-number":["GA-101071485"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22CIII\/00042"],"award-info":[{"award-number":["PI22CIII\/00042"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PID2022-139195OB-I00"],"award-info":[{"award-number":["PID2022-139195OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.medj.2025.100919","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:23:13Z","timestamp":1763155393000},"page":"100919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early screening for Alzheimer\u2019s disease: A scientific, ethical, and value-based framework for targeted screening in at-risk individuals"],"prefix":"10.1016","volume":"6","author":[{"given":"Fangya","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6504-4579","authenticated-orcid":false,"given":"Eva","family":"Carro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2025.100919_bib1","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.medj.2025.100919_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-143006","article-title":"Biomarkers in Sporadic and Familial Alzheimer's Disease","volume":"47","author":"Lista","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.medj.2025.100919_bib3","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.medj.2025.100919_bib4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease","volume":"26","author":"Barth\u00e9lemy","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2025.100919_bib5","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200861","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease","volume":"217","author":"Barth\u00e9lemy","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.medj.2025.100919_bib6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.medj.2025.100919_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer's disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.medj.2025.100919_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102834","article-title":"Decreased salivary lactoferrin levels are specific to Alzheimer's disease","volume":"57","author":"Gonz\u00e1lez-S\u00e1nchez","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.medj.2025.100919_bib9","first-page":"131","article-title":"Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin","volume":"8","author":"Carro","year":"2017","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.medj.2025.100919_bib10","first-page":"945","article-title":"Reduced Salivary Lactoferrin Levels in Early-Onset Alzheimer's Disease","volume":"15","author":"Antequera","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.medj.2025.100919_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78031-9","article-title":"Urinary metabolic phenotyping for Alzheimer's disease","volume":"10","author":"Kurbatova","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.medj.2025.100919_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51837-y","article-title":"Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer's disease","volume":"9","author":"Kenny","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.medj.2025.100919_bib13","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/alz.12311","article-title":"Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel","volume":"17","author":"Babiloni","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.medj.2025.100919_bib14","article-title":"Natural language processing in Alzheimer's disease research: Systematic review of methods, data, and efficacy","volume":"17","author":"Shakeri","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.medj.2025.100919_bib15","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3233\/JAD-180638","article-title":"Ethical Arguments Concerning the Use of Alzheimer's Disease Biomarkers in Individuals with No or Mild Cognitive Impairment: A Systematic Review and Framework for Discussion","volume":"66","author":"Smedinga","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.medj.2025.100919_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1474-4422(25)00162-0","article-title":"The International Working Group recommendations on cognitively unimpaired individuals","volume":"24","author":"Villain","year":"2025","journal-title":"Lancet Neurol."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025003460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025003460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:59:01Z","timestamp":1778921941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634025003460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666634025003460"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2025.100919","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early screening for Alzheimer\u2019s disease: A scientific, ethical, and value-based framework for targeted screening in at-risk individuals","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2025.100919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100919"}}